Crowdonomics
All companies
Breaking Normal logo

Breaking Normal

Operating

BREAKING NORMAL INC.

Healthcare · Encinitas, CA

Visit website

Because all things normal must come to an end Putting REAL back into REAL-ationships

Post-money valuation ⓘ
$2.0M
As of Oct 2019 · from Reg CF Offering (2019) · pre-money + amount raised, not a traded price
Total raised
$36,716
Across 1 round since 2019
Latest share price
$2.00
Reg CF Offering (2019) offering price

Financials

FY2017–FY2018 · from SEC filings · hover any figure for its source
$0
2017
$0
2018
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2017
FY2018
Income statement
Revenue
$0
$0
Cost of goods sold
$0
$0
Net income
$0
$0
Taxes paid
$0
$0
Balance sheet
Cash
$0
$0
Accounts receivable
$0
$0
Total assets
$0
$0
Short-term debt
$0
$0
Long-term debt
$0
$0
Total liabilities
$0
$0
Other
Headcount
—
1

Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited; no pill means the filing didn’t state one. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.

Valuation over rounds

Post-money = pre-money + amount raised · caps marked
$2.0M
post-money
Reg CF Offering (2019)

A dashed amber step is a SAFE/note valuation cap — a conversion ceiling agreed for that instrument, not a priced valuation of the company. Steps are not comparable across bases.

Fundraising history

Reg CF Offering (2019)ClosedReg CF · Common Equity · via StartEngine
Raised $36.7K / $107KInvestors 38Post-money $2M

Team

2 people
Daniel EisenmanFounder
FOUNDER, CEO

Daniel Eisenman graduated Pre-Med from Emory University with a BS (Key Acronym) in Biology. Before applying to medical school to stay on the path of "NORMAL" as people advised him, he decided to "take a year off."

Florence Enueme
Executive Assistant-Marketing

Florence is an MBA with a concentration in marketing. She has been actively involved in business marketing, digital marketing, human resources and other management/business consulting positions. She studied extensively Human Resource Management and acquire an MBA with a concentration in Marketing.

Names and titles as disclosed on StartEngine. Bios and photos come from the platform campaign page and may be out of date.

Reg CF annual-report compliance

Delinquent

Filed 0 of 7 annual reports (FY2019–FY2025)

Missing: 2019, 2020, 2021, 2022, 2023, 2024, 2025

38 investors
holder-count proxy

Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.

SEC filings

  • Form C-UOct 11, 20220001665160-22-002722
    EDGAR
  • Form C-UOct 3, 20190001665160-19-000974
    EDGAR
  • Form C/ASep 24, 20190001665160-19-000957
    EDGAR
  • Form CJul 3, 20190001665160-19-000756
    EDGAR
Source: ManualCIK 0001777867DEShare price $2.00

About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.